The European Medicines Agency (EMA) has recommended a number of changes regarding the use of fosfomycin-based antibiotics, including recommending the suspension of use of pediatric and intramuscular ...

Fosfomycin is a granule for oral solution that’s prescribed for uncomplicated urinary tract infections (UTIs). It’s available as the brand-name drug Monurol. The cost of fosfomycin with and without ...

Escherichia coli is the most common cause of bacterial prostatitis. Findings from a small study suggest it could be an effective, safe, and attractive alternative to fluoroquinolones, bacterial ...

Learn everything you need to know about Fosfomycin-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings, ...

SAN DIEGO — High cure rates can be achieved with fosfomycin in patients with chronic prostatitis — many of whom are resistant to the current first-line treatment of fluoroquinolones — according to ...

"The escalating public health issue of antimicrobial resistance and emergence of highly resistant organisms demands immediate attention and innovative therapeutic solutions. The approval of CONTEPO is ...

Review the side-effects of Fosfomycin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

Fosfomycin is effective against Gram-positive and Gram-negative bacteria, including drug-resistant strains, and is economically viable for treating uncomplicated UTIs. A meta-analysis of 22 studies ...

The FDA approved an intravenous (IV) formulation of fosfomycin (Contepo) to treat adults with complicated urinary tract infection (cUTI), including acute pyelonephritis, caused by susceptible ...

On the basis of sequence analysis, HppE is a member of the cupin superfamily, characterized by an antiparallel β-barrel (cupa is the Latin term for small barrel) 10. Non-haem mononuclear ...

Prediction of early death risk in the elderly with cancer: Results of a prospective multicentric study of 364 patients under chemotherapy No significant financial relationships to disclose. This is an ...